Target intelligence / Profile preview

Protein phosphatase 1 regulatory subunit 8 (PPP1R8)

Target
PPP1R8
Molecular classification
Other, Enzyme modulator, RNA-binding protein, Endoribonuclease
01

Overview

Protein phosphatase 1 regulatory subunit 8 (PPP1R8) is a nuclear protein that acts primarily as a regulatory subunit and inhibitor of serine/threonine-protein phosphatase 1 (PP1), controlling its activity in the nucleus[1][2][7]. PPP1R8 has multiple isoforms generated by alternative splicing. Two isoforms serve as specific inhibitors of type 1 serine/threonine protein phosphatases and bind (but do not cleave) RNA, possibly targeting PP1 to RNA-associated substrates; these are also implicated in pre-mRNA splicing, DNA binding, and may act as transcriptional repressors[1][2][3][7]. A third isoform (gamma) lacks the phosphatase inhibitory function but functions as a site-specific endoribonuclease (comparable to bacterial RNase E), cleaving single-stranded RNA at specific A+U-rich regions in a magnesium-dependent manner[1][2][3]. PPP1R8 is essential for cell proliferation and is involved in cell signaling pathways such as β-adrenergic signaling and cAMP-dependent PKA activation[1]. Associated diseases include Xia-Gibbs syndrome and arthrogryposis, distal, type 1A. There are no current drugs directly targeting PPP1R8 in clinical use, and the protein is not considered a routine clinical biomarker[1][2][3][5][7].

Other names
Nuclear inhibitor of protein phosphatase 1NIPP1Nuclear subunit of PP-1Activator of RNA decayARD-1NIPP-1Protein phosphatase 1 regulatory inhibitor subunit 8Nuclear inhibitor of protein phosphatase-1 alphaNuclear inhibitor of protein phosphatase-1 betaRNase EPRO2047
02

Biological functions

Regulation of protein phosphatase-1 (PP1) activity (inhibitory regulator)RNA bindingEndoribonuclease activity (isoform-dependent)Transcriptional repression (binds DNA)Cell proliferation
03

Disease associations

Cancer (implicated in cell proliferation and pathways relevant to tumorigenesis)Xia-Gibbs syndromeArthrogryposis, distal, type 1APotential role in other diseases linked to PP1 dysregulation
04

Safety considerations

No direct therapeutics or safety profiles known; inhibition or dysregulation could potentially impact cell cycle, RNA processing, and widespread nuclear phosphatase activity

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory subunit 8 (PPP1R8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory subunit 8 (PPP1R8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call